Evidence map›Paper›PMID 34335182›Full record

ArticleFrontiers in molecular neuroscience2021

Cell-Type-Specific High Throughput Toxicity Testing in Human Midbrain Organoids.

Henrik Renner, Katharina J Becker, Theresa E Kagermeier, Martha Grabos, Farsam Eliat, Patrick Günther, Hans R Schöler, Jan M Bruder

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Henrik RennerDepartment for Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Katharina J BeckerDepartment for Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Theresa E KagermeierDepartment for Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Martha GrabosDepartment for Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Farsam EliatDepartment for Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Patrick GüntherDepartment for Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Hans R SchölerDepartment for Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Jan M BruderDepartment for Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Max Planck Institute for Molecular Biomedicine · DEUniversity of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxicity testing is a crucial step in the development and approval of chemical compounds for human contact and consumption. However, existing model systems often fall short in their prediction of human toxicity

Indexed as

automationhigh throughputmidbrainorganoidsscreeningtoxicity testing

Identifiers

PMID34335182
PMCPMC8321240
OpenAlexW3183441645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.